AI, Pharma Services and Tariffs: The Healthcare Outlook from HPE New York
In mid-October, McDermott Will & Schulte’s Healthcare Private Equity New York conference brought healthcare leaders together to analyze the key challenges and trends shaping the industry in 2025. For one busy day, attendees heard from a series of panels that...Navigating Rehab M&A in 2025: Insights from Paul Martin of Martin Healthcare Advisors
The rehabilitation M&A market is showing signs of renewed vigor in 2025 after a period of moderation. With easing interest rates and persistent sector fragmentation, deal activity is picking up as private equity and strategic buyers position for consolidation. To...Reimbursement Changes and Home Health Outlook
Sponsored by CLA Over the summer, the home health industry faced some new potential headwinds. On June 30, the Centers for Medicare & Medicaid Services (CMS) issued its proposed rule for calendar year (CY) 2026, which proposes significant rate adjustments for the...
Health System M&A Pulse
For U.S. health systems, the 2025 market has been volatile, to say the least. From Medicare and Medicaid cuts to escalating costs, health systems have had to adapt to a sweep of changes in the industry. These headwinds have taken a toll on M&A volume, as health...Megadeals in Healthcare: A 2025 Mid-Year Review and Outlook
Healthcare megadeals, defined as transactions valued at $1 billion or more, slowed notably in the first half of 2025, according to data captured in the LevinPro database. There were 18 megadeals announced during the first half of 2025, a 33% decline from the 27 deals...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
